SCHEMBL2228088

SCHEMBL2228088

C1CNC2=C(C1)NCN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19689034 0.83 OR51E2 (0.39)
SCHEMBL8866832 0.70 OR51E2 (0.47)
SCHEMBL8866835 0.65 OR51E2 (0.43)
SCHEMBL634528 0.65 OR51E2 (0.33)
SCHEMBL29425335 0.65
SCHEMBL16738070 0.62 OR51E2 (0.37)
SCHEMBL11720970 0.61 CRBN (0.50)
SCHEMBL5056719 0.61 OR51E2 (0.39)
SCHEMBL22908210 0.61
SCHEMBL22908208 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115583958-A Synthesis method of dihydrothia (oxa) zole [3',2':1,5] dihydroimidazole [4,5-b ] piperidine derivative 河南师范大学 2023-01-10 CN claimed
CN-115583958-A Synthesis method of dihydrothia (oxa) zole [3',2':1,5] dihydroimidazole [4,5-b ] piperidine derivative 河南师范大学 2023-01-10 CN disclosed
EP-2647647-A2 Thiopeptide precursor protein, gene encoding it and uses thereof Novartis AG (CH) 2013-10-09 EP disclosed
US-20110183374-A1 THIOPEPTIDE PRECURSOR PROTEIN, GENE ENCODING IT AND USES THEREOF NOVARTIS AG 2011-07-28 US disclosed
EP-2178907-A1 THIOPEPTIDE PRECURSOR PROTEIN, GENE ENCODING IT AND USES THEREOF Novartis Ag (CH) 2010-04-28 EP disclosed
WO-2009019289-A1 THIOPEPTIDE PRECURSOR PROTEIN, GENE ENCODING IT AND USES THEREOF NOVARTIS AG (CH) 2009-02-12 WO disclosed